Canadian from hantavirus-hit cruise ship tests positive
bbc - The individual is one of four former passengers on the MV Hondius isolating on Vancouver Island, British Columbia.
AI Summary: A Canadian passenger tested positive after an Andes‑virus outbreak aboard a cruise ship, and French authorities report the strain matches known South American viruses. Public health teams began targeted testing, contact tracing and onboard monitoring as experts debate what constitutes “close contact,” balancing realistic containment with the mild panic such exotic pathogens tend to inspire.
- Canada confirms hantavirus cases; testing and isolation underway (3)
- Defining close contact: contact‑tracing challenges and outbreaks at sea (3)
- Sequencing shows South American strain; ship arrival and WHO stance (4)
- All Other Stories
Canada confirms hantavirus cases; testing and isolation underway
Defining close contact: contact‑tracing challenges and outbreaks at sea
Sequencing shows South American strain; ship arrival and WHO stance
All Other Stories
What to know about new Ebola outbreak that has killed 65 people in Congo
medicalxpress - Africa's top public health body has confirmed a new Ebola outbreak in Congo's Ituri province, the 17th since the disease first emerged in the country in 1976.
AI Summary: Health authorities have confirmed a fresh Ebola outbreak in a remote province of the Democratic Republic of Congo that has killed roughly 65 people. Public-health teams are scrambling to trace contacts, ramp up surveillance, and deploy vaccines and treatments amid logistical and security hurdles. Containment hinges on rapid mobilization and local cooperation.
- Confirmed Ituri outbreak: cases, deaths and on-the-ground response (4)
- Vaccine shortages, high lethality and push for new vaccines (3)
- WHO declares global health emergency; international response underway (4)
- All Other Stories
Confirmed Ituri outbreak: cases, deaths and on-the-ground response
Vaccine shortages, high lethality and push for new vaccines
WHO declares global health emergency; international response underway
All Other Stories
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
Cyril Erameh / nature - Nature Medicine, Published online: 15 May 2026; doi:10.1038/s41591-026-04402-wAn open-label, randomized controlled phase 2 trial comparing favipiravir with ribavirin for the treatment of mild-to-moderate Lassa fever in Nigeria found that favipiravir was s…
AI Summary: An open-label, randomized Phase 2 trial of favipiravir for Lassa fever reported encouraging results, suggesting antiviral benefit where few options exist. The study offers early clinical proof-of-concept, especially important for endemic West African settings, and calls for larger trials to confirm efficacy, optimize dosing, and assess deployment logistics.